(Q46793942)

25 December 2017

title

Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study (English)

1 reference

25 December 2017

1 reference

Carboni I

1

1 reference

25 December 2017

de Felice C

series ordinal

2

1 reference

25 December 2017

Bergamin A

series ordinal

3

1 reference

25 December 2017

Chimenti S

series ordinal

4

1 reference

25 December 2017

publication date

1 November 2005

1 reference

25 December 2017

Journal of the European Academy of Dermatology and Venereology

published in

1 reference

25 December 2017

volume

19 Suppl 3

1 reference

25 December 2017

page(s)

11-13

1 reference

25 December 2017

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01331.X

Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01331.X

Calcium homeostasis remains unaffected after 12 weeks' therapy with calcitriol 3 microg/g ointment; no correlation with extent of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01331.X

Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-3083.2005.01331.X

10.1111/J.1468-3083.2005.01331.X

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017